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Abstract
 
Nonobese diabetic (NOD) mice develop spontaneous autoimmune diabetes that results from
the destruction of insulin secreting 
 
 
 
 cells by diabetogenic T cells. The time and location of the
encounter of autoantigen(s) by naive autoreactive T cells in normal NOD mice are still elusive.
To address these issues, we analyzed diabetes development in mice whose spleen or pancreatic
lymph nodes (panLNs) had been removed. Excision of panLNs (panLNx) at 3 wk protected
mice against insulin autoantibodies (IAAs), insulitis, and diabetes development almost com-
pletely, but had no effect when performed at 10 wk. The protection afforded by panLNx at
weaning was not due to modifications of the immune system, the absence of autoreactive T
cells, or the increase in the potency of regulatory T cells. That panLNs are dispensable during
adult life was confirmed by the capacity of 10-wk-old panLNx irradiated recipients to develop
diabetes upon transfer of diabetogenic T cells. In contrast, splenectomy had no effect at any
age. Partial excision of mesenteric LN at 3 wk did not prevent accelerated diabetes by cyclo-
phosphamide as panLNx did. Thus, in normal NOD mice, autoreactive T cell initial priming
occurs in LNs draining the target organ of the disease from 3 wk of age.
Key words: insulin-dependent diabetes mellitus • lymph node excision • splenectomy • T cell 
activation • autoimmunity
 
Introduction
 
Nonobese diabetic (NOD)
 
*
 
 mice develop spontaneous au-
toimmune diabetes that shares many features with human
type 1 diabetes. The disease results from the destruction of
insulin secreting 
 
 
 
 cells mediated by autoreactive T cells.
Several findings have suggested that the development of the
disease comprises several stages. Until around 3–4 wk of
age all the islets are free from lymphocytic infiltration,
suggesting that the thymus-derived autoreactive T cells re-
main naive during this period. From 3–4 wk of age the first
signs of a nondestructive insulitis appear, indicating that ac-
tivation and proliferation of self-reactive T cells is initiated.
This age is also critical for the establishment/maintenance
of a transient dominant tolerance by protective T cells that
prevent 
 
 
 
 cell attack. The breaking down of self-tolerance,
a consequence of a disequilibrium between regulatory and
effector T cells, occurs from around 12 wk of age and re-
sults in 
 
 
 
 cell destruction and diabetes onset (1, 2). A key
event in the development of the disease is the activation of
naive autoreactive T cells by APCs bearing diabetogenic
Ag: when and where does this activation occur? Regarding
the site of the initial priming of naive anti-
 
 
 
 cell T cells,
three possibilities can be envisaged. First, the presence of
APCs loaded with diabetogenic peptides inside the islets
may indicate that Ag presentation takes place inside the is-
lets (3). It can be objected that naive T cells essentially mi-
grate into secondary lymphoid organs, whereas activated T
cells preferentially home to nonlymphoid tissues (4–6). In
this line, we showed that upon transfer into NOD-scid re-
cipients only activated/memory CD62L
 
 
 
 T cells enter in-
side the islets. However, some naive CD62L
 
 
 
 T cells from
young animals migrate to the periphery of the islets (7)
where macrophages and dendritic cells are normally present
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and may exert antigen-presenting function (8). Second, the
spleen provides an appropriate environment for the prim-
ing of T cells by APCs presenting blood-borne Ags. Such
Ags may be islet Ags themselves, as shown after 
 
 
 
 cell in-
jury (3) or molecules from diverse pathogens that cross-
react with diabetogenic Ags. Deduced from what is known
on T cell activation by locally introduced foreign Ag,
priming of naive autoreactive T cells in the LN draining
the pancreas is a third possibility. Transfer of unmanipu-
lated dendritic cells from young NOD mice did prevent di-
abetes only if they were originating from pancreatic LNs
(panLNs), possibly by altering the balance between regula-
tory and effector T cells (9). This indicates that APCs from
panLN and not from other LN bear peptides related to the
disease. Activation of autoaggressive cells was also shown to
occur in the panLN of mice with 
 
 
 
 cells expressing the nu-
clear SV40T Ag (10) and in NOD mice transgenic for a di-
abetogenic TCR (BDC2.5/NOD; reference 11).
In BDC2.5/NOD, 
 
 
 
90% of the T cells are CD4
 
 
 
 Tg
cells and are easily detectable, whereas in normal NOD au-
toreactive T cells mediating the disease are rare cells be-
longing to the CD4 and CD8 lineages and cannot be phe-
notypically analyzed. Expression of autoimmunity requires
activation of the self-reactive T cells, and thus the onset of
diabetes in regular NOD mice, the rapid transfer of diabe-
tes in immunosuppressed animals by spleen T cells (1), and
the acceleration of the disease in young animals by cyclo-
phosphamide (12) reveal the presence of primed anti-
 
 
 
 T
cells. Therefore, to gain information on the site and time of
initial activation of 
 
 
 
 cell reactive T cells in normal NOD
mice, diabetes development was analyzed after excision of
the spleen and the panLN at different ages. Our results
showed that initial activation of anti-
 
 
 
 cell T cells occurs
around 3 wk of age in panLN.
 
Materials and Methods
 
Mice.
 
NOD-Nk, NOD-NON-Thy1
 
a
 
, NOD.scid, BDC2.5/
NOD, BDC2.5 C
 
 
 
0
 
/
 
0
 
, and C57BL/6 mice were bred in our
own facilities under specific pathogen-free conditions. BDC2.5/
NOD and BDC2.5 C
 
 
 
0/0
 
 mice were a gift from D. Mathis and
C. Benoist (Institut de Génétique et de Biologie Moléculaire et
Cellulaire, Strasbourg, France).
The cumulative incidence of diabetes in our NOD-Nk and
BDC2.5/NOD colonies reaches 80 and 30% in females and 40
and 20% in males, respectively, by 8 mo of age. In the BDC2.5
C
 
 
 
0/0
 
 colony, diabetes developed in 75% of the mice between 3
and 5 wk of age.
 
Cell Preparation.
 
Single cell suspensions of spleen, peripheral,
pancreatic, periaortic, and mesenteric LNs (perLNs, panLNs,
PALNs, and MLNs, respectively) were prepared in RPMI 1640
using a homogenizer. After one wash, cell viability was deter-
mined by trypan blue exclusion.
 
Antibodies.
 
The following mAbs were used purified or conju-
gated to biotin or FITC: anti-Thy 1.1 (HO.22), anti-Thy-1
(42–21), anti-Thy 1.2 (30-H.12), anti-CD44 (IM-7), and anti-
CD62L (MEL-14). PE–anti-B220 (RA3–6B2), –anti-CD62L, –anti-
CD8 and –streptavidin, and APC–anti-CD4 were purchased from
BD Biosciences. Extravidin-FITC was from Sigma-Aldrich.
 
Immunofluorescence Staining.
 
Cells were pelleted in 96-well
plates and stained with 20 
 
 
 
l of medium (PBS supplemented with
2% FCS and 5 mM sodium azide) or biotin-, PE-, or FITC-
labeled antibodies at an appropriate concentration 30 min on ice,
followed by Extravidin-FITC or PE-streptavidin. Cells were then
washed twice and resuspended in PBS containing 1% formalde-
hyde. Annexin-V–FITC/propidium iodide (PI) staining to detect
apoptotic cells was performed using an apoptosis detection kit
from Beckman Coulter. Flow cytometric analysis was performed
using a FACScan™ and CELLQuest™ software (Becton Dickin-
son). Data were collected from analysis of 5,000–10,000 cells.
 
Surgical Excision of panLN (panLNx), MLN (MLNx), and Sple-
nectomy (Sx).
 
Mice were anesthetized (0.01 ml/g body weight
of a 2.5% solution of Avertin [Aldrich Chimie], intraperitoneally)
and surgery was performed under a dissection microscope. The
animal was placed on its right flank and a dorsoventral incision in
the skin and muscles was made over the spleen. Lateral retraction
of the spleen, the pancreas, the stomach, and the intestines al-
lowed clearing the cranial side of the kidney. The two panLNs
were exposed by careful blunt dissection. The vessels emerging
from the hilus of each LN were grasped with two pairs of forceps
and crushed. The LN was excised by gentle tractions of the for-
ceps nearest the node. The proximal forceps were maintained a
few seconds before being released. Incisions were closed with
wound clips.
To remove the posterior end of the MLN, a ventral incision
was made. The intestine loops were gently reflected to the right
to expose the mesentery. The small posterior node of the mesen-
teric chain was excised as described for panLNs.
To splenectomize mice, the spleen was exposed, gently lifted
on the tips of curved forceps, and blood vessels were sectioned
with an ophthalmic cautery (Moria). 
Sham-operated animals were anesthetized and their abdomen
incised and closed as described.
 
Migration of Lymphocytes in Lymphnodectomized (panLNx) Mice.
 
Splenocytes from congenic NOD-NON-Thy1
 
a
 
 mice (9-wk-
old) containing 30 
 
 
 
 10
 
6
 
 T cells were injected intravenously to
NOD mice (Thy-1
 
b
 
) panLNx or sham-operated at 3 wk of age,
 
 
 
2 mo after surgery. 16 h later, mice were killed and cell sus-
pensions of their spleen, perLN, and MLN were individually
prepared. Each cell population was labeled with biotin-anti-
Thy-1.1 and FITC-anti-Thy-1.2 antibodies followed by PE-
streptavidin. The frequency of donor type Thy-1.1
 
 
 
 cells was
determined.
 
T Cell Proliferation Assays.
 
Responses to KLH and anti-CD3
were tested in mice panLNx and sham-operated at 3 wk of age, 3
mo after surgery. Complete culture medium consisted in RPMI
1640 containing 7% FCS, 1% penicillin/streptomycin, 4 mM-
glutamine, 10 mM Hepes, 5 
 
  
 
10
 
 
 
5
 
 M 2-ME.
For KLH responses, mice were immunized with 200 
 
 
 
g KLH
in CFA, in the tail base. PALNs and MLNs were removed 5 d
later. T cells were enriched by panning on Petri dishes coated
with goat anti–mouse Ig antibodies. 2 
 
 
 
 10
 
5
 
 T cells of each pop-
ulation were cultured with 2 
 
 
 
 10
 
5
 
 control or antigen-pulsed
APCs prepared as follows. Normal spleen cells depleted of T cells
with anti–Thy-1 (clone 42–21) 
 
 
 
 C (Low-Tox rabbit comple-
ment; Cedarlane), used as a source of APCs, were then cultured
for 18 h in complete medium alone or with 100 
 
 
 
l/ml KLH, be-
fore irradiation with 30 Gy.
For anti-CD3-induced T cell response, 10
 
5
 
 T cell–enriched
suspensions of perLN and spleen cells were cultured with 10
 
5
 
 ir-
radiated control APCs, in the presence of 10 
 
 
 
g/ml purified anti-
CD3 antibody. 
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All cultures were set in triplicate in 96-well culture plates and
pulsed for the last 18 h of a 3 d culture with 1 
 
 
 
Ci 
 
3
 
H TdR/well
(5 Ci/mmol; Amersham Biotech) before being harvested for liq-
uid scintillation counting.
 
Adoptive Transfer of Diabetes.
 
NOD/Nk male mice aged 8 wk
were irradiated with 7.5 Gy the day before transfer of cells.
NOD.scid recipients were used at 4–6 wk of age.
To detect the presence of diabetogenic T cells in sham-oper-
ated and panLNx mice, spleen cell suspensions were prepared in-
dividually, and split equally into two parts. Each spleen cell
aliquot was injected into one recipient. Whether diabetes devel-
oped into only one or both recipients, the donor spleen was con-
sidered as containing anti-
 
 
 
 cell T cells.
To determine whether panLNs are required for transfer of dia-
betes by primed anti-
 
 
 
 cell T cells, 8-wk-old male NOD mice
were subjected to panLNx 2 wk before irradiation. These recipi-
ents were transferred with 5 
 
 
 
 10
 
6
 
 T cells (85% pure after passage
on nylon wool column) from spleens of regular diabetic donors.
Mice were tested twice a week for glycosuria. After a positive
urine test, blood glucose levels were determined with test strips
and by a quantitative colorimetric assay (Reflolux; Boehringer).
Animals showing glycemia higher than 300 mg/dl were classified
as overtly diabetic.
 
Cyclophosphamide Treatment.
 
Cyclophosphamide (CY; En-
doxan-Asta; Laboratoires Lucien) was injected intraperitoneally
twice at a 2-wk interval at a dose of 200 mg/kg (1 mg/ml in sa-
line). Mice were monitored every 2–3 d for 4 wk as described
above.
 
Insulin Autoantibody Assay.
 
A 96-well filtration plate micro
insulin autoantibody (IAA) assay was performed as described pre-
viously (13). Briefly, 
 
125
 
I-insulin (Amersham Biotech) of 24,000
cpm was incubated with 5 
 
 
 
l of serum with and without cold
human insulin, respectively, at a 1:5 dilution of serum for 3 d at
4
 
 
 
C in an appropriate buffer. 50 
 
 
 
l of 50% protein A/8% protein
G Sepharose (Amersham Biotech) were added to the incubation
in a Multi-Screen 96-well filtration plate (Millipore). The plate
was shaken for 60 min at 4
 
 
 
C. After washing, scintillation liquid
was added to each well, and then counted. The results were cal-
culated on the basis of the difference in cpm between the well
without cold insulin and the well with cold insulin (
 
 
 
 cpm) and
expressed as an index: index 
 
 
 
 (sample 
 
 
 
 cpm 
 
 
 
 negative con-
trol)/(positive control 
 
 
 
 cpm 
 
 
 
 negative control) 
 
 
 
 100. Serum
samples were collected at 8 and 12 wk of age.
 
Histopathology.
 
Pancreases and salivary glands were excised,
fixed in Bouin’s solution, and processed for paraffin embedding.
Four sections (5 
 
 
 
m) taken at 100 
 
 
 
m intervals were stained ac-
cording to the hematein-eosin-safranin method. The proportion
of infiltrated islets was based on the observation of at least 20 islets
per specimen.
 
Statistical Analysis.
 
Pooled data were computed as mean 
 
 
 
SEM and were compared using Student’s 
 
t
 
 test. When appropri-
ate results were analyzed using Chi-square test, Mann Whitney
test, or two-way analysis of variance (ANOVA). The Kaplan-
Meier estimation was used to calculate diabetes incidence, and
the log-rank test was used for the evaluation of significance.
 
Results
 
Excision of PanLN at Weaning Prevents Diabetes Develop-
ment.
 
To determine the relative importance of spleen,
panLN, and islets in the primary activation of diabetogenic
T cells, the incidence of diabetes was analyzed in mice
whose spleen or panLN were surgically removed at differ-
ent ages.
Splenectomy, performed at 3 or 10 wk of age, had no ef-
fect on diabetes prevalence (P 
 
  
 
0.05; Fig. 1 A).
After panLNx at weaning (3 wk), diabetes development
was greatly reduced (P 
 
  
 
0.0001) compared with sham-
operated animals (20 and 100% were diabetic at 28 wk of
age, respectively). panLNx performed at 4 wk of age
slightly reduced diabetes incidence (P 
 
  
 
0.05), and had no
effect in adult (10 wk) mice (P 
 
 
 
 0.05; Fig. 1 B).
Histological analysis of the pancreas over a 38 wk period
showed that, in mice panLNx at weaning, insulitis re-
mained moderate, with 50–80% of the islets showing no
signs of infiltration (Fig. 2 A). In sham-operated mice the
Figure 1. Incidence of sponta-
neous diabetes in female NOD
mice Sx (A) or panLNx (B) at
different ages. 
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frequency of intact islets significantly decreased with time,
and was lower than in panLNx mice at 18 and 38 wk of
age. This frequency was overestimated from 18 wk of age
because insulitis was evaluated in nondiabetic mice only,
while 
 
 
 
50% and 
 
 
 
85% of control mice were diabetic at
18 and 38 wk of age, respectively. Thus, the difference in
insulitis severity between control and panLNx mice is
greater than that illustrated on Fig. 2 A. No sign of pancre-
atitis was observed in panLNx mice.
Interestingly, excision of panLNs did not prevent devel-
opment of sialitis, indicating that inhibition of autoimmune
response is specific for 
 
 
 
 cells.
These data indicate that diabetes development requires
the presence of panLNs for at least the first 4 wk of life.
 
panLNx at Weaning Had No Consequence on the Localiza-
tion and TCR-mediated Responses of the T Cell Pool.
 
We
verified whether excision of panLNs at weaning resulted in
modifications of the T cell pool behavior that could explain
the reduced diabetes prevalence.
The cellularity of spleen and LN was not modified (data
not shown). The frequency of B (not shown) and T cells
(Table I) in secondary lymphoid organs remained un-
changed. Lymphocytes from normal NOD mice congenic
at the Thy-1 locus injected intravenously into panLNx and
control mice homed to the spleen, perLN, and MLN with
equal efficiency (not shown).
In panLNx mice the responses of T cells to anti-CD3 in
vitro and the generation of KLH-specific primary effector
CD4 cells in vivo, were indistinguishable from those of
control mice (P 
 
  
 
0.05) in two independent experiments
(Fig. 3). Thus, panLNx does not seem to perturb T cell
production and functions.
 
Protection Does Not Result from the Absence of 
 
 
 
 Cell–specific
T Cells in panLNx Mice.
 
Excision of panLNs at weaning
did not prevent the production of anti–
 
 
 
 cell T cells by
the thymus and their settlement in lymphoid organs. This
was demonstrated in adoptive transfer of diabetes experi-
ments where 57 and 46% of the spleens from panLNx
mice, 4–6 mo after surgery, contained T cells able to in-
duce the disease in irradiated and NOD.scid recipients, re-
spectively. After injection of sham-operated mouse spleen
cells the transfer of diabetes occurred earlier in 100 and
75% of irradiated and NOD.scid recipients, respectively.
Statistical analysis showed that the frequencies of positive
spleens in both groups were not significantly different
(P 
 
  
 
0.05; Table II). The late and slow diabetes onset in
recipients of panLNx mouse cells likely corresponded to
the time required for priming of naive autoreactive T cells
in an animal with intact panLNs. In contrast, antigen-
experienced anti–
 
 
 
 cells from control mice could exert
their function rapidly.
Figure 2. Histopathological
analysis of islets in the pancreas
of NOD mice after panLNx at 3
wk of age. (A) Severity of insuli-
tis was determined at various
times after surgery. Sham-oper-
ated animals served as controls.
(B) Insulitis in mice panLNx at 3
wk, injected with CY at 8 and
10 wk and killed at 12 wk of age.
 
Table I.
 
Lymphoid Organ T Cell Contents after Excision of 
panLN at 3 Wk of Age
 
Percentage of cells
Groups
Time after
panLN Spleen perLN MLN
Sham 1 mo 41.4 
 
  
 
2.2 75.5 
 
  
 
1.5 70.8 
 
  
 
1
panLNx 35.2 
 
  
 
3.4 68.6 
 
  
 
1.7 74.9 
 
  
 
2
Sham 3 mo 46.9 
 
  
 
4.7 67.4 
 
  
 
1.9 –
panLNx 47.3 
 
  
 
4.7 68.9 
 
  
 
2.9 –
Control 8 mo 41.3 67.2 34.2
panLNx 38.2 
 
  
 
1.3 60.8   3.9 26.3   2.4
The percentage of T cells was determined after labeling with anti-Thy
1.2 FITC. Control mice were sham-operated animals at 1 and 3 mo after
surgery and age-matched female NOD mice at 8 mo. Mean   SEM of
three animals or mean of two mice (P   0.05 control vs. LNxpanLNx).373 Gagnerault et al.
CY Fails to Induce Diabetes in panLNx Mice. CY, an
immunosuppressive drug, accelerates diabetes in NOD
mice in which insulitis is installed, that is from around 5 wk
of age. The disease results from regulatory T cell elimina-
tion that allows autoreactive T cells to exert their function
(12). After two injections, 2 wk apart, of CY administered
4–5 wk after surgery (when mice were aged 7–8 wk), dia-
betes developed in only 20% of panLNx mice, whereas
94% of sham-operated animals became diabetic during the
following 3–4 wk (P   0.0001) (Fig. 4 A). Interestingly,
these results are similar to the incidence of spontaneous di-
abetes in the two groups of mice at 28 wk of age. Analysis
of insulitis in 12-wk-old mice resistant to CY treatment
showed that 50% of the islets in panLNx mice were free of
infiltrate versus only 6% in control mice (Fig. 2 B). To ver-
ify the specific effect of panLNx, mice MLNx at 3 wk of
age were treated with CY when 8 wk old. Diabetes devel-
oped in MLNx mice as efficiently as in control mice (P  
0.05; Fig. 4 B).
These results suggest that the protection afforded by
panLNx does not result from an increased inhibitory con-
trol of the pathogenic T cells, nor the absence of autoreac-
tive T cells, as shown above, but is rather consequential to
the lack of priming of these cells that remain harmless.
Pancreatic LNs Are Not Required for the Migration of Primed
Anti–  Cell T Cells into the Islets. The above results indi-
cate that panLNs are required for the initial priming of
anti–  cell T cells. The fact that panLNx at 10 wk had no
effect suggests that once primed diabetogenic T cells are
present, panLNs are dispensable. To strengthen this notion
we transferred diabetogenic T cells into irradiated recipi-
ents whose panLN had been excised. All mice became dia-
betic with a kinetic of disease induction similar to that ob-
served in irradiated control recipients (Fig. 5). Thus, once
self-reactive T cells have been primed in the donors’
panLNs the latter are not anymore required, and in their
absence diabetogenic T cells probably expand in other re-
cipients’ lymphoid organs and/or the islets themselves.
panLNx at Weaning Prevents IAA Development. IAA
level analysis showed that 50% of NOD mice 12 wk old
Figure 3. Proliferative responses of T cells to anti-CD3 and KLH after
panLNx at 3 wk. T cells were tested 3 mo after surgery. Anti-CD3 re-
sponse was performed on antibody coated dishes (top). T cells were primed
in vivo 5 d before restimulation in vitro by KLH-pulsed APC (bottom).
Table II. Spleens from panLNx Mice Contain Cells Capable of Transferring Diabetes
Incidence of diabetes (at weeks)
Donor Recipients 3 4 5 6 7 8 9 10 11
Control Irrad. 5/7 5/7 6/7 7/7
(%) 71 71 86 100
panLNx 0/7 0/7 2/7 3/7 3/7 3/7 3/7 3/7 4/7a
(%) 0 0 29 43 43 43 43 43 57
Control scid 0/8 0/8 1/8 2/8 3/8 4/8 6/8 6/8 6/8
(%) 0 0 12 25 37 50 75 75 75
panLNx 0/13 0/13 0/13 0/13 0/13 4/13 4/13 5/13 6/13b
(%) 0 0 0 0 0 31 31 38 46
Splenocytes from each donor were equally injected intravenous in two recipients. The results are from one experiment with irradiated mice and from
two independent experiments with NOD.scid recipients, and are expressed as the number of spleens transferring diabetes/the total number of spleens
tested. Control mice comprised sham-operated mice in two experiments, and age-matched mice in a third one. 
a 2 analysis: P   0.0507.
b 2 analysis: P   0.05.374 Priming of Autoreactive T Cells in NOD Mice
were positive. The same score was found with serum sam-
ples of mice panLNx at 10 wk. In contrast, only 10 and 0%
of the sera collected from mice panLNx at 3 and 4 wk of
age, respectively, were positive (the panLNx-4wk mice
tested were still free of diabetes at 20 wk). The IAA levels
in control and MLNx mice aged 8 wk were similar (Fig. 6).
Thus, panLNx at 3–4 wk of age greatly affected the pro-
duction of one of the first autoantibodies detected in
NOD, but had no effect when panLNx was performed in
adults.
T Cell Activation in panLNs Is Detectable in BDC2.5 but
Not in Normal NOD Mice. In normal NOD mice, the
low frequency of and lack of specific markers for autoreac-
tive T cells in panLNs impedes the direct visualization of
their activation. However, diabetogenic cells are detectable
in BDC2.5/NOD mice in which activated transgenic CD4
cells were shown to reside specifically in the pancreatic is-
lets and their draining LNs (11). To test whether any sign
of activation could be detected in normal mice, we ana-
lyzed the frequency of memory/activated CD62LloCD44hi
cells among CD4 cells from spleen, MLN, and panLN in
NOD, BDC2.5/NOD, and BDC2.5 C 0/0 at different
ages. We confirmed that this population is increased in the
panLNs of transgenic mice only, and show that this in-
crease is detectable from 3 wk of age, but not earlier (Table
III). In addition, we observed in the panLN of BDC2.5/
NOD transgenics a 2–3-fold increase in the frequency
of CD4 cells expressing an intermediary phenotype
(CD44 CD62Lint), characteristic of the transition stage be-
tween naive and activated cells (Fig. 7). These intermediary
cells were absent from perLNs. This indicates that the stim-
ulation of cells does occur in panLNs and the increase in
activated cells does not result from a preferential migration
of activated cells into panLNs compared with other LNs.
In the three strains of mice the percentage of CD4
CD62LloCD44hi cells was increased in the spleen of mice
3-wk-old, compared with 2-wk-old mice, but cells with
the transitional phenotype were absent. This, together with
the lack of effect of splenectomy, favor accumulation rather
than activation of primed cells inside the spleen. Indeed,
activated CD4 cells exit responding LNs as early as 2 d after
antigen encounter, and primarily recirculate through the
spleen (14).
The phenotypic changes observed in panLNs came with
an increase in the fraction of early apoptotic CD4 An-
nexin-V PI  cells in the panLNs of regular and transgenic
NOD mice, compared with BALB/c mice. However, this
increase was greater in the panLNs of BDC2.5 transgenics
than in normal NOD mice, and was not observed in
perLNs and MLNs of any mice (Table IV). Although dif-
ferent pathways induce apoptosis, it is tempting to relate
this observation to activation-induced cell death (15).
Although phenotype analysis could not evidenced an in-
crease in T cell activation in normal NOD mice, the in-
crease in apoptotic cells likely points panLNs as distinct
from other LNs in NOD mice.
Discussion
  cell–reactive T cells are generated in the thymus and
recirculate through peripheral lymphoid organs until anti-
gen is encountered. The time and location of this encoun-
ter in normal NOD mice are still elusive. To address these
issues, we analyzed diabetes development in mice whose
spleen, part of the MLN, or panLNs had been removed.
Our data indicate that panLNs play a pivotal role in autore-
active T cell initial priming that takes place from 3 wk of
age. This age, referred to as the first check point in the pro-
gression of the disease (16), corresponds to the first signs of
Figure 4. CY injection failed to induce spontaneous diabetes in mice
panLNx at 3 wk, whereas it accelerated diabetes in mice MLNx at 3 wk.
CY was administered 5 and 7 wk after excision of panLN or MLN. Inci-
dence of the disease was followed for 28 d.
Figure 5. panLNs are dispensable for the adoptive transfer of diabetes.
NOD mice were panLNx before irradiation and injection of splenocytes
from diabetic mice ( , normal recipients;  , Sham-operated recipients;
 , panLNx recipients).375 Gagnerault et al.
insulitis (8), and to the emergence of the regulation of the
autoimmune process (17,18).
Ablation of panLNs at 3 wk protected mice against dia-
betes almost completely. The protection afforded by
panLNx at weaning was not due to modifications of the
immune system. First, removal of panLNs at 3 wk of age
did not modify the number, composition and reactivity of
T cells, as shown by the proliferation of the latter in re-
sponse to anti-CD3 in vitro and to KLH in vivo. Second,
panLNx did not result in the absence of autoreactive T
cells or the increase in the potency of regulatory T cells.
Thus, it appears that panLNx at weaning induces a long-
lasting prevention of   cell–specific T cell activation.
When panLNs were removed at 4 wk the protection was
incomplete, indicating that priming had already taken place
in some mice. At 10 wk of age excision of panLNs did not
influence diabetes progression, showing that at this time
panLNs were dispensable. This was confirmed by the ca-
pacity of 10-wk-old panLNx irradiated recipients to de-
velop diabetes upon transfer of T cells from diabetic mice.
On the contrary, splenectomy had no effect at any age, and
MLNx at 3 wk of age did not prevent acceleration of dia-
betes by CY. This indicates that initial priming of islet-
reactive T cells does not occur in the spleen, although this
organ is the largest reservoir of pathogenic T cells (19), nor
in other abdominal LNs. That islets were the primary site
of anti–  cell priming could not be directly tested, but if it
were the case, ablation of panLNs would had no effect.
These observations show that out of the three locations
where antigen encounter can occur, that is the spleen, the
panLN and the islets, panLNs are the site of initial priming
of   cell–specific T cells. However, primed anti–  cells
were not readily detectable in panLNs of young mice, as al-
ready reported for panLNs of diabetic mice (20). Indeed,
Figure 6. Levels of insulin autoantibodies are greatly
reduced in mice LNx at weaning. Serum samples were
collected at 8 or 12 wk of age.  /n, number of posi-
tive samples/total samples.
Table III. Frequency of CD44hiCD62Llo Cells Among CD4 Cells in Different Organs at Various Ages
Organs Age (wk) NOD n BDC n BDC C 0/0 n
2-way ANOVAa
effect of
Spleen 2 17.9   2.6 3 13.3   0.7 5 13.3   0.9 3 Age: P   0.0008
3 23.8   1.4 10 28.9   2.3 8 20.4   3.3 7 Strain: NS
5 20.9   1.9 4 26.6   1.6 8 24.2   4.3 6 Interaction: NS
MLN 2 8.3   0.3 5 9.4   0.7 5 11.0   1.3 6 Age: NS
3 8.3   1.0 7 9.2   0.9 8 12.3   1.1 11 Strain: NS
5 9.6   0.9 4 12.6   1.4 8 10.7   2.5 4 Interaction: NS
panLN 2 8.9   2.0 2 10.3   1.6 5 10.0   0.6 3 Age: P   0.0002
3 13.4   1.2 5 25.5   0.7 8 28.4   3.7 11 Strain: P   0.008
5 14.9   1.6 3 34.5   2.8 8 29.2   3.1 4 Interaction: NS
7–8 10.7   1.7 3 29.7   1.7 6
n   number of tested animals.
aTwo-way analysis of variance showed an effect, on the percentage of CD4 CD44 CD62Llo cells, of age in both spleen and panLNs, and an effect
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panLN cells from mice aged 4–5 wk transferred diabetes in
only 20% of recipients (data not shown). This is likely due
to the fact that primed T cells leave rapidly responding LNs
and do not return to LNs (14). In addition, the presence of
insulitis in panLNx mice suggests either that some priming
in panLNs may occur before 3 wk of age but does not in-
clude all the T cell reactivities required for diabetes devel-
opment, or that priming of some autoreactive T cells may
occur in other lymphoid organs but without the contribu-
tion of panLNs disease does not occur.
The present results fit with the notion that antigen out-
side organized lymphoid tissues is ignored (21, 22), notably
because naive cells do not migrate into non-lymphoid tis-
sues due to the absence of expression of appropriate homing
receptors on endothelium (6). The establishment of insulitis
requires the expression on endothelial cells of vascular ad-
dressins involved in homing of activated as well as naive
cells. The events that induce the expression of these adhe-
sion molecules on postcapillary venules are unknown but
critical to understanding diabetes progression. After infiltra-
tion is initiated, lymphocytes, including both naive and acti-
vated T cells, get organized in the vicinity of these venules
(23). There, intraislet APCs that bear antigen can eventually
prime naive T cells and allow the diabetogenic process to
proceed. Intraislet proliferation of lymphocytes was sug-
gested by the findings that the infiltrate from each individual
islet was generated by oligoclonal expansion of a few pre-
cursors (24). Thus, when panLNx was performed in 10-wk-
old mice, effector T cells were already antigen experienced,
insulitis was present and priming of naive autoreactive T
cells could possibly occur inside the islets. However, such
intraislet activation is not necessary since thymectomy at 6
wk of age that stops production of naive autoreactive T cells
has no effect on diabetes incidence (18).
Excision of panLNs, which provide the required environ-
ment for   cell antigens encounter, impeded, not only the
development of the Th1 arm of the autoimmune response,
but also humoral immunity. In mice panLNx at 3–4 wk,
IAA levels were drastically decreased. The notion that an
immune response to insulin is in place early in life in the ma-
jority of NOD mice and children developing type 1 diabetes
has emerged (13). Our results show that humoral immunity
to insulin in NOD requires the LNs draining the pancreas.
Absence of activation of autoreactive T cells in mice less
than 3 wk of age was already demonstrated in two experi-
mental models of mice expressing antigens transgenically in
the pancreatic islets (10, 25), and in BDC2.5/NOD mice
expressing an unknown natural islet protein (11), and
NOD mice injected with a diabetogenic CTL clone (26).
This results from the unavailability of autoantigens in the
panLNs of very young animals (11). Later on, pancreatic
auto antigens were shown to be first presented to autoreac-
tive T cells in the panLNs (10, 11). Upon injection, T cells
from diabetic mice located in the panLNs before entering
other LNs and rapidly expressed CD25 (27). Similarly,
shortly after transfer of BDC2.5 T cells, proliferating cells
localized specifically in panLNs (11). Antigens are pre-
sented to naive T cells by dendritic cells, which, when they
originate from panLNs, prevent diabetes after injection into
young NOD mice. Other LN dendritic cells could not
achieve this goal, confirming the presence in panLNs of
disease-related antigens (9).
Table IV. Distribution of Early Apoptotic CD4 Cells in LNs
Percentage of apoptotic CD4 cells
perLN MLN panLN
BALB/c 3 wk 5.5 (2) 5.6 (2) 3.9   0.8 (3)
5–6 wk 2.1 (2) 2.0   0.2 (5) 3.0   0.6 (5)
NOD 3 wk 2.5   0.2 (4) 3.8   0.6 (5) 6.5   0.7 (7)
5–6 wk 2.2   0.3 (4) 3.8   0.3 (7) 8.1   1.7 (9)
BDC 3 wk – 3.0   0.2 (3) 7.8   0.3 (6)
5–6 wk 2.2   0.4 (3) 4.2   0.5 (5) 16.0   6.0 (5)
The percentage of Annexin V PI  cells among CD4 cells is shown. The
number of animals tested is indicated in parentheses. Two-way analysis
of variance showed an effect of strains (P   0.015) without an effect of
age (P   0.05) on the percentage of apoptotic cells in the panLN.
Figure 7. Surface expression of CD44 and CD62L on CD4 T cells
from panLN of normal NOD (A) and BDC2.5/NOD mice (B). In
BDC2.5/NOD mice a subset with an intermediate phenotype
CD44 CD62Lint is highly increased compared with NOD mice, showing
the transition step between naive CD44loCD62L  and activated/memory
CD44hiCD62L  cells. Cells were successively gated on side vs. forward
scatter, to select alive cells, and on CD4 expression.377 Gagnerault et al.
It was important to confirm in standard NOD mice con-
clusions drawn from mice expressing self-antigens trans-
genically in the pancreatic islets. This work shows that
panLNs are a requisite for the initiation of autoimmune di-
abetogenic activation which takes place from 3 wk of age,
the first checkpoint in the diabetogenic process.
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